About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2025 Clareo Health. All rights reserved.

UNKNOWN

Safety and Immunogenicity of an Inactivated Vaccine Against COVID-19 in Medical Workers

NCT04795414•Ruijin Hospital

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

SARS-CoV-2 InfectionCovid19

Interventions

SARS-CoV-2 Vaccine(Vero Cell), Inactivated

Locations

1

China

Locations (1)

Ruijin Hospital affiliated to Shanghai JiaoTong University School of Medicine

Shanghai, Shanghai Municipality, China

Key Dates

Start Date

January 14, 2021

Primary Completion Date

April 30, 2022

Completion Date

January 31, 2023

Last Updated

March 19, 2021

Related Studies

RECRUITINGPhase 3

Randomized Double-Blind Placebo-Controlled Trial EValuating Baricitinib on PERSistent NEurologic and Cardiopulmonary Symptoms of Long COVID

NCT06631287

Long COVIDSars-CoV-2 Infection+2 more

RECRUITINGPhase 1

T Cell Therapy Opposing Novel COVID-19 Infection in Immunocompromised Patients

NCT05141058

SARS-CoV-2 Infection

RECRUITINGPhase 3

A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease

NCT06679140

COVID-19 SARS-CoV-2 Infection

Clinical Outcomes and Pharmacotherapy Effectiveness in the VA Health Care System (COPE-VA)

NCT06160128

COVID-19, SARS-CoV-2 InfectionRSV+1 more

RECRUITINGPhase 3

A Study to Learn About a COVID-19 Vaccine in Healthy Adults 50 Through 64 Years of Age

NCT07300839

COVID-19SARS-COV-2 Infection

Physiology of Long COVID-19 and the Impact of Cardiopulmonary Rehabilitation on Quality-of-Life and Functional Capacity

NCT05566483

Post-acute Sequelae of SARS-CoV-2 Infection

View all related studies

Contacts

ZhiTao Yang

CONTACT

+8613611965436 yangzhitao@hotmail.fr

Xiaoqi Yu

CONTACT

+8613817390935 yuxiaoqi_03@163.com

Sponsors

Lead Sponsor

Ruijin Hospital

Detailed Description

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 19, 2021Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions